Greenstone LLC Introduces Ziprasidone HCL Capsules
PEAPACK, N.J., April 2012 — Greenstone LLC, the U.S.-based generic pharmaceutical subsidiary of
Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Ziprasidone HCl Capsules to its everexpanding
generic pharmaceutical product line. The product is offered in dosage strengths of 20 mg, 40
mg, 60 mg, and 80 mg capsules.
Greenstone’s Ziprasidone HCl Capsules product is the authorized generic of, and thereby fully
substitutable for, GEODON® (ziprasidone HCl) Capsules. Their new authorized generic complements
Greenstone’s consistently growing line of products, and is backed by the power and scale of Pfizer’s 162-
year worldwide reputation for a commitment to integrity, quality, and supply reliability. As a subsidiary
of Pfizer, Greenstone operates under the same values and commitment to bring quality authorized
generics to customers, payers, and the patients they serve.
See the Full Prescribing Information for Greenstone’s Ziprasidone HCl Capsules at
http://www.greenstonellc.com/product-list.aspx. For more information about Greenstone LLC and its
products, visit http://greenstonellc.com. GEODON® is a registered trademark of Pfizer Inc.
Back to Press Releases
Greenstone LLC, established in 1993, is a wholly owned subsidiary of Pfizer Inc,
one of the largest pharmaceutical companies in the world. Greenstone, which focuses
on customer service, markets a broad line of quality Authorized Generics —
along with an expanding line of ANDA (Abbreviated New Drug Application) generics.
Greenstone Authorized Generics, well known for having the same physical characteristics
as the innovators' brands, are supported by state-of-the-art distribution and operations
services. Greenstone is working with numerous brand pharmaceutical companies to
assist in their "post-exclusivity" planning, with a focus on Authorized Generics.
The company offers a robust product pipeline that highlights quality generic equivalents
to some of the best-selling branded pharmaceuticals. Greenstone LLC will continue
to offer numerous future product opportunities for pharmacies and its trade partners.